RTW Investments’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
RTW Investments's IMVT Position: Q3 2026 in Review
RTW Investments held its Immunovant (IMVT) position steady in Q3 2026 at 3,177,849 shares worth $107M. The position accounts for 1.08% of the portfolio, ranked #34.
RTW Investments first reported a position in IMVT in Q4 2019 and has held it in 11 quarters since. The position peaked at $351M in Q4 2020. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.
- RTW Investments held 3,177,849 shares of Immunovant worth $107M as of Q3 2026.
- RTW Investments left its Immunovant share count unchanged in Q3 2026.
- Immunovant made up 1.08% of RTW Investments's portfolio in Q3 2026, its #34 holding.
- RTW Investments first reported a position in Immunovant in Q4 2019 and has held it in 11 quarters since.
- RTW Investments's Immunovant position peaked at $351M in Q4 2020.
- 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.
Based on RTW Investments's 13F filing for Q3 2026, filed 16 Nov 2026.